Phibro Animal Health (PAHC) Stock Price

Phibro Animal Health Price

NASDAQ·CLOSED
35.63USD+1.08 (+3.08 %)
Market closed

Revenue has compounded at 6.4% per year over the past 19 years to 1.30 B USD. Earnings per share have grown at 19.5% per year over the last 17 years. Phibro Animal Health's net margin stands at 3.7%, down from 6.5% several years earlier. Phibro Animal Health currently offers a dividend yield of about 1.35%. The payout ratio is around 41% of earnings. The dividend has grown at 8.3% per year over the past 11 years. Analysts set a median price target of 45.90 USD, implying 28.8% above the current price. Of 9 analysts, 1 rate the stock a buy — an overall Sell consensus. The stock trades about 24% above its 52-week low.

Phibro Animal Health stock price

Volume
Ex-Dividend
Details

Stock Price

ⓘ

How to Read This Chart

This chart tracks the historical stock price of Phibro Animal Health over time. You can switch between daily, weekly, and monthly views and select custom time ranges — from a single day to the full available history. Use the toggle to view price changes in absolute currency terms or as a percentage change relative to the starting date.

Total Return vs. Price Return

The "Total Return" toggle includes reinvested dividends on top of the pure price movement. This is critical because dividends can account for a significant portion of long-term returns. Historically, roughly 40 % of the S&P 500's total return has come from dividends. Always compare total return when evaluating a stock's real performance against a benchmark.

Intraday Price Data

When viewing a one-day time frame, the chart displays real-time intraday price movements. This is useful for observing how Phibro Animal Health stock reacts to market openings, earnings releases, or breaking news throughout the trading session.

What to Look For

Look for long-term trends (sustained upward or downward movements over months and years), support and resistance levels (price zones where the stock repeatedly bounces or reverses), and volatility (how much the price fluctuates day to day). Comparing Phibro Animal Health's price chart to a market index like the S&P 500 can reveal whether the stock is outperforming or underperforming the broader market.

Phibro Animal Health Stock Price History
DatePhibro Animal Health Price
8/19/202635.63 USD
8/18/202634.56 USD
8/14/202634.36 USD
8/13/202634.06 USD
8/12/202633.61 USD
8/10/202634.29 USD
8/7/202634.29 USD
8/6/202635.50 USD
8/5/202635.65 USD
8/4/202636.46 USD
8/3/202637.15 USD
7/31/202636.33 USD
7/30/202636.45 USD
7/29/202636.46 USD
7/27/202635.01 USD
7/23/202634.04 USD
7/22/202633.81 USD
7/21/202633.86 USD
7/20/202633.05 USD
7/17/202633.31 USD
7/16/202634.52 USD
7/15/202633.74 USD
7/14/202633.04 USD
7/13/202632.26 USD
7/10/202632.07 USD
7/9/202632.38 USD
7/8/202632.42 USD
7/7/202633.12 USD
7/6/202632.87 USD
7/2/202633.26 USD
7/1/202632.10 USD
6/30/202631.40 USD
6/29/202631.93 USD
6/26/202631.69 USD
6/25/202631.83 USD
6/24/202631.36 USD
6/23/202630.53 USD
6/22/202631.01 USD
6/18/202631.17 USD
6/17/202631.76 USD
6/16/202631.58 USD
6/15/202632.04 USD
6/12/202631.96 USD
6/11/202631.00 USD
6/10/202632.74 USD
6/9/202632.65 USD
6/8/202631.76 USD
6/5/202633.00 USD
6/4/202633.39 USD
6/3/202631.19 USD
6/2/202628.63 USD
6/1/202629.59 USD
5/29/202631.42 USD
5/28/202632.23 USD
5/27/202633.20 USD
5/26/202633.43 USD
5/22/202632.98 USD
5/21/202633.12 USD
5/20/202634.33 USD
5/19/202633.90 USD
5/18/202634.18 USD
5/15/202634.37 USD
5/14/202636.15 USD
5/13/202635.26 USD
5/12/202636.58 USD
5/11/202636.32 USD
5/8/202640.00 USD
5/7/202643.16 USD
5/6/202658.50 USD
5/5/202656.24 USD
5/4/202654.68 USD
5/1/202654.89 USD
4/30/202653.18 USD
4/29/202652.50 USD
4/28/202654.29 USD
4/27/202656.14 USD
4/24/202655.16 USD
4/22/202653.97 USD
4/21/202654.09 USD
4/20/202656.51 USD
4/17/202657.07 USD
4/16/202653.88 USD
4/15/202655.01 USD
4/14/202659.02 USD
4/13/202659.58 USD
4/10/202657.89 USD
4/9/202659.09 USD
4/8/202658.66 USD
4/7/202655.66 USD
4/6/202654.94 USD
4/2/202655.52 USD
4/1/202654.76 USD
3/31/202655.31 USD
3/30/202653.35 USD
3/27/202653.88 USD
3/26/202655.82 USD
3/25/202657.01 USD
3/24/202655.48 USD
3/23/202653.80 USD
3/20/202650.76 USD
3/19/202652.38 USD
3/18/202652.23 USD
3/17/202652.51 USD
3/16/202651.17 USD
3/13/202649.47 USD
3/12/202649.00 USD
3/11/202650.07 USD
3/10/202650.43 USD
3/9/202648.78 USD
3/6/202647.92 USD
3/5/202649.59 USD
3/4/202651.89 USD
3/3/202652.27 USD
3/2/202654.54 USD
2/27/202654.59 USD
2/26/202654.70 USD
2/25/202653.10 USD
2/24/202651.46 USD
2/23/202651.52 USD
2/20/202652.80 USD
2/19/202651.85 USD
2/18/202651.08 USD
2/17/202652.29 USD
2/13/202652.26 USD
2/12/202651.27 USD
2/11/202651.52 USD
2/10/202651.74 USD
2/9/202651.85 USD
2/6/202653.07 USD
2/5/202650.00 USD
2/4/202641.00 USD
2/3/202641.31 USD
2/2/202641.91 USD
1/30/202640.15 USD
1/29/202639.89 USD
1/28/202638.80 USD
1/27/202639.52 USD
1/26/202639.48 USD
1/23/202639.01 USD
1/22/202641.61 USD
1/21/202641.95 USD
1/20/202641.08 USD
1/16/202641.07 USD
1/15/202640.06 USD
1/14/202639.87 USD
1/13/202640.46 USD
1/12/202639.83 USD
1/9/202639.44 USD
1/8/202639.72 USD
1/7/202639.43 USD
1/6/202639.54 USD
1/5/202638.37 USD
1/2/202637.30 USD
12/31/202537.36 USD
12/30/202537.51 USD
12/29/202537.73 USD
12/26/202538.17 USD
12/24/202537.74 USD
12/23/202537.39 USD
12/22/202537.83 USD
12/19/202537.25 USD
12/18/202540.41 USD
12/17/202540.60 USD
12/16/202540.40 USD
12/15/202540.67 USD
12/12/202540.15 USD
12/11/202540.76 USD
12/10/202539.87 USD
12/9/202538.28 USD
12/8/202540.08 USD
12/5/202539.16 USD
12/4/202540.77 USD
12/3/202541.39 USD
12/2/202540.68 USD
12/1/202540.76 USD
11/28/202541.88 USD
11/26/202543.23 USD
11/25/202544.33 USD
11/24/202543.08 USD
11/21/202541.63 USD
11/20/202540.81 USD
11/19/202541.38 USD
11/18/202543.38 USD
11/17/202545.06 USD
11/14/202545.10 USD
11/13/202544.70 USD
11/12/202545.32 USD
11/11/202545.33 USD
11/10/202545.83 USD
11/7/202543.76 USD
11/6/202543.04 USD
11/5/202541.15 USD
11/4/202542.11 USD
11/3/202543.37 USD
10/31/202542.06 USD
10/30/202541.86 USD
10/29/202541.19 USD
10/28/202541.68 USD
10/27/202541.70 USD
10/24/202542.33 USD
10/23/202541.05 USD
10/22/202540.19 USD
10/21/202541.45 USD
10/20/202540.62 USD
10/17/202539.72 USD
10/16/202538.57 USD
10/15/202539.14 USD
10/14/202537.64 USD
10/13/202536.58 USD
10/10/202536.39 USD
10/9/202537.17 USD
10/8/202537.11 USD
10/7/202537.62 USD
10/6/202537.79 USD
10/3/202538.32 USD
10/2/202539.01 USD
10/1/202540.80 USD
9/30/202540.46 USD
9/29/202539.15 USD
9/26/202538.81 USD
9/25/202538.04 USD
9/24/202538.25 USD
9/23/202538.42 USD
9/22/202538.40 USD
9/19/202539.86 USD
9/18/202540.54 USD
9/17/202538.58 USD
9/16/202539.01 USD
9/15/202539.53 USD
9/12/202539.62 USD
9/11/202541.19 USD
9/10/202541.18 USD
9/9/202541.23 USD
9/8/202539.43 USD
9/5/202539.45 USD
9/4/202539.07 USD
9/3/202538.20 USD
9/2/202536.69 USD
8/29/202537.07 USD
8/28/202538.46 USD
8/27/202532.20 USD
8/26/202532.64 USD
8/25/202531.94 USD
8/22/202532.46 USD
8/21/202531.55 USD
Access this data via the Eulerpool API
Get Free API Key

Phibro Animal Health Revenue, EBIT, Net Income

  • 3 Years

  • 5 Years

  • 10 Years

  • 25 Years

  • Max

Revenue
EBIT
Net Income
Details
Date
Revenue
EBIT
Net Income
Jan 1, 2023
977.89 M USD
71.85 M USD
32.61 M USD
Jan 1, 2024
1.02 B USD
53.32 M USD
2.42 M USD
Jan 1, 2025
1.30 B USD
101.24 M USD
48.26 M USD
Jan 1, 2026 (e)
1.50 B USD
110.14 M USD
124.97 M USD
Jan 1, 2027 (e)
1.55 B USD
113.79 M USD
136.03 M USD
Jan 1, 2028 (e)
1.60 B USD
117.61 M USD
149.88 M USD
Jan 1, 2029 (e)
1.65 B USD
121.18 M USD
177.36 M USD
Jan 1, 2030 (e)
1.70 B USD
124.83 M USD
196.47 M USD

Phibro Animal Health Income Statement, Balance Sheet, Cash Flow Statement

Last updated Aug 21, 2026, 10:12 AM
 
REVENUEB USD
REVENUE GROWTH%
GROSS MARGIN%
GROSS INCOMEM USD
EBITM USD
EBIT MARGIN%
NET INCOMEM USD
NET INCOME GROWTH%
DIV.USD
DIV. GROWTH%
SHARESM
201520162017201820192020202120222023202420252026e2027e2028e2029e2030e
0.750.750.760.820.830.800.830.940.981.021.301.501.551.601.651.70
8.250.401.737.330.98-3.384.1313.093.724.0927.4315.513.343.363.062.97
31.5531.8232.4632.4431.8832.0032.5330.2530.5030.7830.7930.7930.7930.7930.7930.79
236.00239.00248.00266.00264.00256.00271.00285.00298.00313.00399.00460.88476.28492.28507.37522.46
87.0085.0097.0098.0073.0069.0074.0078.0071.0053.00101.00110.00113.00117.00121.00124.00
11.6311.3212.7011.958.828.638.888.287.275.217.797.357.307.327.347.31
60.0082.0064.0064.0054.0033.0054.0049.0032.002.0048.00124.00136.00149.00177.00196.00
-2,100.0036.67-21.95–-15.63-38.8963.64-9.26-34.69-93.752,300.00158.339.689.5618.7910.73
0.400.400.400.420.480.480.480.480.480.480.480.480.480.48––
100.00––5.0014.29–––––––––––
39.9840.0040.3640.5240.5040.5040.5040.5040.5040.7240.9640.9640.9640.9640.9640.96
Details

Income Statement Key Figures

ⓘ

Revenue and Revenue Growth

Revenue is the starting point of every income statement — it measures the total sales Phibro Animal Health generates from its core business. Revenue growth (expressed as year-over-year percentage change) is one of the most important indicators of business momentum. Sustained growth above 10 % annually is generally considered strong, while declining revenue is a serious warning sign that demands investigation.

Gross Margin

Gross margin = (Revenue − Cost of Goods Sold) ÷ Revenue. It reveals what percentage of each dollar of revenue Phibro Animal Health retains after direct production costs. High gross margins (above 50 %) are typical of asset-light businesses like software and brands, while capital-intensive industries like manufacturing often operate below 30 %. Compare Phibro Animal Health's gross margin to industry peers and track it over time to spot improving or deteriorating pricing power.

EBIT and EBIT Margin

EBIT measures operating profit — what remains after subtracting all operating expenses (including R&D, sales, and administrative costs) from gross profit. The EBIT margin shows this as a percentage of revenue. Because it excludes interest and taxes, EBIT allows fair comparisons between companies with different debt levels and tax jurisdictions. A rising EBIT margin indicates improving operational efficiency.

Net Income and Earnings Per Share (EPS)

Net income is the company's final profit after all expenses, interest, and taxes. Dividing net income by the number of shares outstanding gives you EPS — the single most influential metric in stock valuation. Consistent EPS growth is the primary driver of long-term stock price appreciation. Always check whether EPS growth comes from genuine profit improvement or from share buybacks reducing the share count.

Shares Outstanding

The total number of shares Phibro Animal Health has issued. A declining share count (through buybacks) boosts EPS and signals management confidence. A rising share count (through stock issuance) dilutes existing shareholders. Always monitor this number alongside EPS to get the full picture of per-share value creation.

Analyst Estimates

The projected figures represent consensus estimates from professional analysts. Compare these forecasts against Phibro Animal Health's historical growth rates to assess whether expectations are realistic. A company that consistently beats consensus estimates tends to see its stock price rewarded over time, while repeated misses erode investor confidence.

Phibro Animal Health stock margins

The Phibro Animal Health margin analysis displays the gross margin, EBIT margin, as well as the profit margin of Phibro Animal Health. The EBIT margin (EBIT/sales) indicates the percentage of sales that remains as operating profit. The profit margin shows the percentage of sales that remains for Phibro Animal Health.

  • 3 Years

  • 5 Years

  • 10 Years

  • 25 Years

  • Max

Gross margin
EBIT margin
Profit margin
Details
Date
Gross margin
EBIT margin
Profit margin
Jan 1, 2021
32.56 %
8.98 %
6.53 %
Jan 1, 2022
30.29 %
8.38 %
5.22 %
Jan 1, 2023
30.50 %
7.35 %
3.33 %
Jan 1, 2024
30.77 %
5.24 %
0.24 %
Jan 1, 2025
30.85 %
7.81 %
3.72 %
Jan 1, 2026 (e)
30.85 %
7.35 %
8.34 %
Jan 1, 2027 (e)
30.85 %
7.35 %
8.79 %
Jan 1, 2028 (e)
30.85 %
7.35 %
9.37 %

Phibro Animal Health Stock Revenue, EBIT, Earnings per Share

The Phibro Animal Health earnings per share therefore indicates how much revenue Phibro Animal Health has generated per share in a given period. The earnings before interest and taxes per share shows how much of the operating profit corresponds to each share. The earnings per share indicates how much of the profit belongs to each share.

  • 3 Years

  • 5 Years

  • 10 Years

  • 25 Years

  • Max

Revenue per Share
EBIT per share
Earnings per Share
Details
Date
Revenue per Share
EBIT per share
Earnings per Share
Jan 1, 2021
20.57 USD
1.85 USD
1.34 USD
Jan 1, 2022
23.26 USD
1.95 USD
1.21 USD
Jan 1, 2023
24.14 USD
1.77 USD
0.81 USD
Jan 1, 2024
25.00 USD
1.31 USD
0.06 USD
Jan 1, 2025
31.65 USD
2.47 USD
1.18 USD
Jan 1, 2026 (e)
36.82 USD
2.69 USD
3.07 USD
Jan 1, 2027 (e)
38.04 USD
2.78 USD
3.34 USD
Jan 1, 2028 (e)
39.32 USD
2.87 USD
3.68 USD

Phibro Animal Health business model & stock analysis

Phibro Animal Health Corp is a globally leading company specializing in the research, development, production, and marketing of animal health products. The company was founded in 1947 and is headquartered in Teaneck, New Jersey, USA. The company originally produced additives and aids for the food industry but recognized the potential of the animal health market in the 1950s and shifted its focus to developing and marketing animal health products. In the 1970s, the company introduced the first antibiotic for agricultural animals. Phibro Animal Health Corp's business model is to manufacture innovative animal health products and sell them to livestock owners, veterinarians, agricultural farms, and other customers worldwide. The company aims to improve the quality of life and production conditions of livestock by focusing on the prevention and treatment of diseases and infections. Phibro Animal Health Corp has two main business segments: Animal Health and Performance. In the Animal Health segment, the company offers products for the prevention and treatment of diseases in livestock such as pigs, poultry, cattle, and fish. These products include vaccines, antibiotics, other medications, as well as feed additives and disinfectants. In the Performance segment, the company offers feed additives and special minerals that are designed to improve the performance and health of livestock. Some of the company's key products include Amprolium, an antibiotic for the treatment of coccidiosis commonly found in poultry; Autogenous Vaccines, customized vaccines tailored to the specific needs of a farm for higher effectiveness; Salinomycin, an antibiotic for the prevention of coccidiosis in poultry; COOL-AID, a feed additive that lowers the body temperature of livestock to improve their well-being; and X-Zelit, a mineral feed additive that enhances phosphorus absorption in dairy cows and increases milk production. Phibro Animal Health Corp operates in over 60 countries, serving livestock owners and agricultural farms worldwide. The company is committed to developing innovative products that contribute to improving the quality of life for livestock and increasing the productivity and profitability of agricultural farms.

Phibro Animal Health SWOT Analysis

Strengths

Phibro Animal Health Corp has several notable strengths that contribute to its competitive advantage in the market:

  • Strong market presence and established reputation in the animal health industry.
  • Diverse portfolio of products and services catering to different animal species and healthcare needs.
  • Robust research and development capabilities, allowing for continuous innovation and product improvement.
  • Strong distribution network, facilitating wide market reach and effective supply chain management.
  • Well-trained and knowledgeable sales force, enabling effective customer engagement and relationship building.

Weaknesses

Despite its strengths, Phibro Animal Health Corp also faces certain weaknesses that may impede its growth and market performance:

  • Dependence on a limited number of key suppliers for raw materials, potentially leading to supply chain disruptions.
  • Relatively high production costs compared to some competitors, affecting price competitiveness.
  • Vulnerability to regulatory changes and evolving industry standards, which may require costly adaptations and compliance measures.
  • Limited geographic presence in certain regions, resulting in missed market opportunities.

Opportunities

Phibro Animal Health Corp can leverage the following opportunities to further expand its market position and profitability:

  • Growing global demand for animal protein, providing an increased market for animal health products.
  • Increasing awareness and focus on animal welfare, driving demand for high-quality healthcare products.
  • Emerging markets with untapped potential, presenting opportunities for market expansion and revenue growth.
  • Advancements in technology and digital solutions, allowing for enhanced product development, distribution, and customer engagement.

Threats

Phibro Animal Health Corp faces certain threats that could potentially hinder its performance and competitive position:

  • Intense competition from other established players and new entrants in the animal health market.
  • Fluctuating prices of key raw materials and ingredients, impacting production costs and overall profitability.
  • Regulatory constraints and potential restrictions on the use of certain chemicals or medications in animal healthcare.
  • Public scrutiny and concerns regarding the environmental impact and sustainability practices of the animal agriculture industry.

Phibro Animal Health Employees

  • 3 Years

  • 5 Years

  • 10 Years

  • 25 Years

  • Max

Phibro Animal Health Employees
Details
Date
Phibro Animal Health Employees
Jan 1, 2018
- Employees
Jan 1, 2019
- Employees
Jan 1, 2020
- Employees
Jan 1, 2021
- Employees
Jan 1, 2022
- Employees
Jan 1, 2023
- Employees
Jan 1, 2024
- Employees
Jan 1, 2025
- Employees

Phibro Animal Health Eulerpool Fair Value

Details

Fair Value Estimate

ⓘ

What Is Fair Value?

Fair value is an estimate of what a stock is truly "worth" based on its financial fundamentals, independent of the current market price. If the calculated fair value is above the current share price, the stock may be undervalued — and vice versa. This chart shows three different fair value approaches so you can cross-check them against each other.

Earnings-Based Fair Value

Calculated by multiplying the current earnings per share (EPS) by the average historical P/E ratio over a selected multi-year period. The smoothing over several years filters out temporary spikes or dips. If this fair value exceeds the market price, it suggests the stock is cheap relative to its earning power.

Example: Fair Value (Earnings) 2022 = EPS 2022 × Average P/E 2019–2021

Revenue-Based Fair Value

Derived by multiplying revenue per share by the average historical price-to-sales ratio. This method is particularly useful for companies with volatile or temporarily depressed earnings, as revenue tends to be more stable than profits. It answers: "At what price has the market historically valued each dollar of this company's sales?"

Example: Fair Value (Revenue) 2022 = Revenue per Share 2022 × Average P/S 2019–2021

Dividend-Based Fair Value

Calculated by dividing the dividend per share by the average historical dividend yield. This approach is most relevant for mature, consistently dividend-paying companies. If the resulting fair value is higher than the current price, it implies the stock offers a better yield than its historical average.

Example: Fair Value (Dividend) 2022 = Dividend per Share 2022 ÷ Average Yield 2019–2021

How to Use This Chart

When all three fair value lines converge above the current price, it strengthens the case that the stock is undervalued. When they diverge, investigate why — it may indicate a structural shift in margins, payout policy, or growth rate. The forward estimates on the right extend the analysis using projected fundamentals, helping you assess whether the current price already reflects future growth expectations.

Phibro Animal Health historical P/E ratio, EBIT multiple, and P/S ratio

Phibro Animal Health annual returns

Details

Annual Return

ⓘ

What This Chart Shows

This chart breaks down 's total annual return into two components: price return (gains or losses from stock price movement) and dividend return (income received from dividend payments). Together, they represent the total return an investor would have earned in each calendar year.

Price Return

Price return measures the percentage change in 's stock price from January 1st to December 31st of each year. Positive bars indicate the stock appreciated; negative bars show a decline. This is the component most investors focus on, but it tells only part of the story — especially for dividend-paying stocks.

Dividend Return

Dividend return represents the income generated from dividends paid during the year, expressed as a percentage of the starting stock price. While it may seem small in any single year (typically 1–4 % for established companies), dividends compound significantly over decades and have historically contributed roughly 40 % of total stock market returns.

What to Look For

Examine how many years showed positive vs. negative returns to gauge consistency. A stock with mostly positive years and small drawdowns suggests lower risk. Also compare 's annual returns to a benchmark index — consistently outperforming the market is a hallmark of a strong investment. Pay attention to the worst years: understanding downside risk is just as important as chasing upside potential.

Phibro Animal Health shares outstanding

The number of shares of Phibro Animal Health was 40.96 M in 2025. This indicates how many shares Phibro Animal Health is divided into. Since shareholders are the owners of a company, each share represents a small portion of the company's ownership.

  • 3 Years

  • 5 Years

  • 10 Years

  • 25 Years

  • Max

Number of stocks
Details
Date
Number of stocks
Jan 1, 2021
40.50 M Stocks
Jan 1, 2022
40.50 M Stocks
Jan 1, 2023
40.50 M Stocks
Jan 1, 2024
40.72 M Stocks
Jan 1, 2025
40.96 M Stocks
Jan 1, 2026 (e)
40.96 M Stocks
Jan 1, 2027 (e)
40.96 M Stocks
Jan 1, 2028 (e)
40.96 M Stocks

Phibro Animal Health Dividend History

13 years of dividend payments

YearAnnual DividendYoY ChangePayments
20260.36USDYTD—3×
Mar 4, 20260.12USD 0.0%1/3
Jun 3, 20260.12USD 0.0%2/3
Sep 2, 2026Declared0.12USD 0.0%3/3
20250.48USD 0.0%4×
Mar 5, 20250.12USD 0.0%1/4
Jun 4, 20250.12USD 0.0%2/4
Sep 3, 20250.12USD 0.0%3/4
Nov 26, 20250.12USD 0.0%4/4
20240.48USD 0.0%4×
20230.48USD 0.0%4×
20220.48USD 0.0%4×
20210.48USD 0.0%4×
20200.48USD 0.0%4×
20190.48USD↑ 14.3%4×
20180.42USD↑ 5.0%4×
20170.40USD 0.0%4×

Phibro Animal Health dividend history and estimates

In 2025, Phibro Animal Health paid a dividend amounting to 0.48 USD. Dividend means that Phibro Animal Health distributes a portion of its profits to its owners.

  • Max

Dividend
Dividend (Estimate)
Details
Date
Dividend
Dividend (Estimate)
Jan 1, 2021
0.48 USD
0.00 USD
Jan 1, 2022
0.48 USD
0.00 USD
Jan 1, 2023
0.48 USD
0.00 USD
Jan 1, 2024
0.48 USD
0.00 USD
Jan 1, 2025
0.48 USD
0.00 USD
Jan 1, 2026
0.48 USD
0.00 USD
Jan 1, 2027 (e)
0.00 USD
0.48 USD
Jan 1, 2028 (e)
0.00 USD
0.48 USD

Phibro Animal Health dividend payout ratio

In 2025, Phibro Animal Health had a payout ratio of 40.73%. The payout ratio indicates the percentage of the company's profits that Phibro Animal Health distributes as dividends.

  • 3 Years

  • 5 Years

  • 10 Years

  • 25 Years

  • Max

Payout ratio
Details
Date
Payout ratio
Jan 1, 2021
35.75 %
Jan 1, 2022
39.54 %
Jan 1, 2023
59.63 %
Jan 1, 2024
808.91 %
Jan 1, 2025
40.73 %
Jan 1, 2026 (e)
15.62 %
Jan 1, 2027 (e)
14.35 %
Jan 1, 2028 (e)
13.03 %

Current Phibro Animal Health forecasts and price targets in August 2026

Analyst Price Targets 2026
Δ MOM Price Target
0.00 %
Buy
11.11 % (1)
Hold
44.44 % (4)
Sell
44.44 % (4)
12M Price Target
45.90
Last Price
35.18
Currency
USD
12M Return Potential
30.47 %
LTM Return
0 %

Phibro Animal Health Analyst Rating Actions

DateFirmActionRatingReliability
5/14/2026
Citigroup
Citigroup
MaintainedNeutral41
11/7/2025
JP Morgan
JP Morgan
MaintainedOverweight62
8/29/2025
B of A Securities
B of A Securities
MaintainedUnderperform68
7/7/2025
JP Morgan
JP Morgan
UpgradeNeutralOverweight62
6/25/2025
Morgan Stanley
Morgan Stanley
MaintainedEqual Weight49
5/8/2025
Morgan Stanley
Morgan Stanley
MaintainedEqual Weight49
2/10/2025
Barclays
Barclays
MaintainedUnderweight55
12/17/2024
Morgan Stanley
Morgan Stanley
MaintainedEqual Weight49
11/12/2024
Barclays
Barclays
MaintainedUnderweight55
8/30/2024
B of A Securities
B of A Securities
MaintainedUnderperform68

Eulerpool Reliability Score (0–100): measures how often a firm’s bullish or bearish calls were directionally correct three months later, blended with the average return following its calls. Every rating we record is stored permanently and scores update continuously; firms with fewer than 3 measured calls are not scored yet.

Phibro Animal Health Earnings Calls

2025

Phibro Animal Health Earnings Estimates & Surprises

DateEPS estimateEPS ActualRevenue EstimatePrice reactionQuarterly report
9/2/20260.73USD-388.87 MUSD-2026 Q4
5/13/20260.73USD-374.36 MUSD-2026 Q3
2/11/20260.68USD-362.75 MUSD-2026 Q2
11/6/20240.31USD--USD-2025 Q1
5/1/20240.31USD-256.33 MUSD-2024 Q3
2/6/20240.29USD-247.14 MUSD-2024 Q2
11/7/20230.30USD-241.04 MUSD-2024 Q1
8/22/20230.36USD-264.72 MUSD-2023 Q4
5/2/20230.32USD-254.25 MUSD-2023 Q3
2/7/20230.33USD-250.30 MUSD-2023 Q2

EESG©

Eulerpool ESG Scorecard© for the Phibro Animal Health stock

40/100
42
Environment
67
Social
12
Governance
E

Environment

20
Scope 1 - Direct Emissions31,330
Scope 2 - Indirect emissions from purchased energy17,272
Scope 3 - Indirect emissions within the value chain—
Total CO₂ emissions48,602
CO₂ reduction strategy
Coal energy
Nuclear power
Animal experiments
Fur & Leather—
Pesticides
Palm Oil—
Tobacco
Genetically modified organisms
Climate concept—
Sustainable forestry—
Recycling regulations
Environmentally friendly packaging
Hazardous substances
Fuel consumption and efficiency
Water consumption and efficiency
S

Social

20
Percentage of female employees33
Percentage of women in management—
Percentage of Asian employees—
Share of Asian management—
Percentage of Hispanic/Latino employees—
Hispano/Latino Management share—
Percentage of Black employees—
Black Management Share—
Percentage of white employees—
White Management Share—
Adult content
Alcohol
Weapons—
Firearms
Gambling
Military contracts
Human rights concept
Privacy concept—
Occupational health and safety
Catholic
G

Governance (Corporate Governance)

4
Environmental reporting
Stakeholder Engagement
Call Back Policies
Antitrust law

The Eulerpool ESG Scorecard© is the strictly copyrighted intellectual property of Eulerpool Research Systems. Any unauthorized use, imitation, or infringement will be actively pursued and may lead to significant legal consequences. For licenses, collaborations, or usage rights, please contact us directly via our contact form. Contact Form to us.

Phibro Animal Health shareholder structure

% Name
7.99904%
BLACKROCK, INC.
BLACKROCK, INC.
5.34226%
FMR LLC
FMR LLC
2.33550%
STATE STREET CORP
STATE STREET CORP
2.19107%
VANGUARD CAPITAL MANAGEMENT LLC
VANGUARD CAPITAL MANAGEMENT LLC
1.51697%
ACADIAN ASSET MANAGEMENT LLC
ACADIAN ASSET MANAGEMENT LLC
1.48643%
GEODE CAPITAL MANAGEMENT, LLC
GEODE CAPITAL MANAGEMENT, LLC
...

Phibro Animal Health Beneficial Ownership Filings (SEC 13D/G)

Free Float
99.3%
Float Shares
-
Shares Outstanding
-
StakeHolderFiling
48.20%
Jack C. Bendheim
Jack C. Bendheim
SEC ↗
48.20%
BFI Co., LLC
BFI Co., LLC
SEC ↗
17.60%
(1) BlackRock, Inc.
(1) BlackRock, Inc.
SEC ↗
15.70%
BlackRock, Inc.
BlackRock, Inc.
SEC ↗
14.60%
Edward C. Johnson 3d
Edward C. Johnson 3d
SEC ↗
14.60%
Abigail P. Johnson
Abigail P. Johnson
SEC ↗
11.03%
The Vanguard Group - 23-1945930
The Vanguard Group - 23-1945930
SEC ↗
11.00%
39-1346018
39-1346018
SEC ↗
11.00%
Lazard Asset Management LLC
Lazard Asset Management LLC
SEC ↗
10.50%
FMR LLC
FMR LLC
SEC ↗

Phibro Animal Health Executives and Management Board

14 members · avg. age 62 · 36 % women

JB

Mr. Jack Bendheim (78)

Chairman of the Board, President, Chief Executive Officer · since 1984

5.28 M USD

Management

LM

Mr. Larry Miller (61)

Chief Operating Officer

2.43 M USD
GD

Mr. Glenn David (54)

Chief Financial Officer

1.27 M USD
DB

Mr. Daniel Bendheim (53)

Executive Vice President - Corporate Strategy, Director · since 2013

1.12 M USD
JW

Ms. Judith Weinstein (56)

Senior Vice President, General Counsel, Corporate Secretary

1.04 M USD
LE

Ms. Lisa Escudero (63)

Senior Vice President - Human Resources

–
JB

Mr. Jonathan Bendheim (49)

Senior Vice President - Global Technology and Talent, Director · since 2024

–

Board of Directors

SG

Mr. Sam Gejdenson (77)

Independent Director

60,000.00 USD
CW

Ms. Carol Wrenn (64)

Independent Director

60,000.00 USD
AB

Mr. Alejandro Bernal (52)

Independent Director

50,000.00 USD
EC

Mr. E. Corcoran (78)

Independent Director

50,000.00 USD
MM

Ms. Mary Malanoski (68)

Independent Director

40,000.00 USD
JL

Ms. Joyce Lee (53)

Independent Director

20,000.00 USD

Frequently asked questions about Phibro Animal Health

Phibro Animal Health Corp is primarily present in various countries and regions. This global company has a wide reach, with its presence prominently seen in North America, Latin America, Europe, and Asia-Pacific. With its headquarters based in the United States, Phibro Animal Health Corp operates across more than 75 countries worldwide. The company's strong international presence allows it to offer its comprehensive range of animal health products and solutions to various markets across the globe.

Phibro Animal Health Corp operates as a diversified global animal health and mineral nutrition company. Their business model focuses on developing, manufacturing, and marketing a wide range of animal health pharmaceuticals and vaccines to improve animal productivity and promote public health. Additionally, the company offers various mineral nutrition products, including specialty ingredients used in animal feed. With a vast portfolio of products and a commitment to innovation, Phibro Animal Health Corp aims to enhance the health and performance of animals worldwide.

Phibro Animal Health Corp is primarily active in the animal health industry.

Some of the main competitors of Phibro Animal Health Corp in the market include Zoetis Inc., Merck Animal Health, Elanco Animal Health, and Boehringer Ingelheim.

Phibro Animal Health Corp is a reputable company with a rich history and background. Originally known as a division of Pharmacia & Upjohn, it became an independent company in 2003. With a mission to provide innovative solutions for animal health and nutrition, Phibro Animal Health Corp has been a market leader for over 40 years. They offer a wide range of products and services to enhance animal productivity and improve the health and well-being of livestock. With a commitment to research and development, Phibro Animal Health Corp continues to drive advancements in the animal health industry, making them a trusted name in the market.

Phibro Animal Health Corp has achieved significant milestones since its inception. The company has expanded its global presence, becoming a leading provider of animal health solutions. Phibro has demonstrated consistent growth through strategic acquisitions and partnerships, enhancing its product portfolio and market reach. Additionally, the company has achieved several regulatory approvals for innovative products, strengthening its competitive edge. Phibro Animal Health Corp has also focused on sustainable practices, ensuring the production of safe and quality animal health products. These milestones reflect the company's commitment to advancing animal care and delivering value to its customers worldwide.

Phibro Animal Health Corp represents a strong commitment to animal health and welfare. They prioritize innovation, research, and development to provide solutions that enhance animal productivity and improve the quality of their lives. With a customer-centric approach, Phibro strives to understand and meet the unique needs of their clients. Their corporate philosophy revolves around driving sustainable growth, fostering meaningful partnerships, and delivering value to stakeholders. By combining expertise, cutting-edge technologies, and a dedication to animal care, Phibro Animal Health Corp establishes itself as a trusted leader in the industry, dedicated to improving animal health worldwide.

Analysts currently set an average price target of 43.86 USD for the Phibro Animal Health stock (median: 45.90 USD), implying +24.7 % versus the latest price. The consensus is based on 9 analyst ratings.

Phibro Animal Health Analyst Price Targets 2026

9 analysts currently rate the Phibro Animal Health stock: 1 recommend buying, 4 holding and 4 selling. For 2026, analysts expect Phibro Animal Health to generate revenue of 1.50 B USD and earnings per share of 3.05 USD.

Phibro Animal Health Analyst Price Targets 2026

Converted at the current exchange rate, the Phibro Animal Health share trades at 30.50 EUR (35.63 USD).

The Phibro Animal Health share (PAHC) is listed on 3 stock exchanges, including: NASDAQ (PAHC), Frankfurt (PB8.F), München (PB8.MU).

Phibro Animal Health Corporation is a global leader in providing products and services to the animal health and nutrition industry. The company's business model is based on providing innovative, high-quality products and services that improve the health and performance of livestock while increasing profitability for animal owners and feed producers. The company offers a wide range of products and services in various sectors of the animal health and nutrition industry. These sectors include animal pharmaceuticals, vaccines, feed additives, and technical services. The animal pharmaceutical sector includes a wide range of antibiotics, antifungals, anti-inflammatories, and other medications for the treatment of pigs, poultry, cattle, and other livestock. The company has a strong pipeline of innovative animal pharmaceuticals that contribute to improving animal health and performance and help animal owners increase their profitability. Phibro Animal Health also offers an extensive range of veterinary vaccines used for the prevention of infectious diseases in animals. The vaccines are both inactivated and live, providing high protection against a variety of diseases. In addition to animal pharmaceuticals and vaccines, the company also offers feed additives that contribute to improving feed efficiency, digestion, and animal performance. Feed additives include probiotics, premixes, enzymes, and other additives. To provide comprehensive service to its customers, Phibro Animal Health also offers technical services such as training, testing, and custom solutions. The company works closely with its customers to understand their needs and provide specific solutions tailored to their requirements. Phibro Animal Health also has a strong presence in the global market, serving customers in over 65 countries. The company has production facilities on four continents and leverages its global presence to offer a wide range of products and services, providing its customers with a comprehensive service offering. Overall, the business model of Phibro Animal Health Corporation is based on providing innovative, high-quality products and services that improve the health and performance of livestock while increasing profitability for animal owners and feed producers. The company has a strong focus on research and development and works closely with its customers to provide specific solutions tailored to their requirements. With its strong presence in the global market, Phibro Animal Health is able to serve customers worldwide and achieve strong profitability in both the short and long term.

The expected revenue of Phibro Animal Health is 1.50 B USD. This figure is based on current financial data and reflects the company's business performance.

The expected profit of Phibro Animal Health is 124.97 M USD. The net profit reflects the company's profitability after deducting all expenses.

The price-to-earnings ratio (P/E) of Phibro Animal Health is currently 11.68. The P/E ratio compares the current share price to the earnings per share and helps investors assess the valuation of the Phibro Animal Health stock.

The price-to-sales ratio (P/S) of Phibro Animal Health is currently 0.97. The P/S ratio compares the market capitalization to the annual revenue and serves as a valuation metric for the Phibro Animal Health stock.

The Eulerpool Quality Score for Phibro Animal Health is 5/10.

The ISIN of Phibro Animal Health is US71742Q1067. The ISIN (International Securities Identification Number) is a globally unique identifier for securities.

The WKN of Phibro Animal Health is A1WZ6P. The WKN (Wertpapierkennnummer) is a six-digit German security identification number.

The ticker of Phibro Animal Health is PAHC. The ticker symbol is used to trade Phibro Animal Health shares on the stock exchange.

Over the past 12 months, Phibro Animal Health paid a dividend of 0.48 USD . This corresponds to a dividend yield of about 1.35 %. For the coming 12 months, Phibro Animal Health is expected to pay a dividend of 0.48 USD.

The current dividend yield of Phibro Animal Health is 1.35 %.

Phibro Animal Health pays a dividend, distributed in the months of , , , .

Phibro Animal Health paid dividends every year for the past 12 years.

For the upcoming 12 months, dividends amounting to 0.48 USD are expected. This corresponds to a dividend yield of 1.35 %.

Phibro Animal Health is assigned to the 'Health' sector.

To receive the latest dividend of Phibro Animal Health from amounting to 0.12 USD, you needed to have the stock in your portfolio before the ex-date on .

The last dividend was paid out on .

In the year 2025, Phibro Animal Health distributed 0.48 USD as dividends.

The dividends of Phibro Animal Health are distributed in USD.

All fundamentals and in-depth analysis of Phibro Animal Health

Our stock analysis for Phibro Animal Health stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of Phibro Animal Health. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.

Phibro Animal Health Stock
Phibro Animal Health Revenue→
Phibro Animal Health Stock
Phibro Animal Health Net Income→
Phibro Animal Health Stock
Phibro Animal Health P/E→
Phibro Animal Health Stock
Phibro Animal Health P/S→
Phibro Animal Health Stock
Phibro Animal Health EBIT→
Phibro Animal Health Stock
Phibro Animal Health Dividend→
Phibro Animal Health Stock
Phibro Animal Health Directors Dealings→
Phibro Animal Health Stock
Phibro Animal Health Stocks→
Phibro Animal Health Stock
Phibro Animal Health Market capitalization→
Phibro Animal Health Stock
Phibro Animal Health Debt→
Phibro Animal Health Stock
Phibro Animal Health Liabilities→
Phibro Animal Health Stock
Phibro Animal Health Equity→
Phibro Animal Health Stock
Phibro Animal Health AAQS→
Phibro Animal Health Stock
Phibro Animal Health Employees→
Phibro Animal Health Stock
Phibro Animal Health ROE→
Phibro Animal Health Stock
Phibro Animal Health ROA→
Phibro Animal Health Stock
Phibro Animal Health ROCE→
Phibro Animal Health Stock
Phibro Animal Health News→
Phibro Animal Health Stock
Phibro Animal Health Analyst Price Targets→

Health Stocks

Phio PharmaceuticalsPHC HoldingsPhoenixBio CoPhathom PharmaceuticalsPhotocure APharvarisPhreesiaPharos IBio CoPHSCPharmosa BiopharmPhysiomicsPharming GroupAll Stocks A–Z →